Direct molecular typing of Bordetella pertussis from clinical specimens submitted for diagnostic quantitative (real-time) PCR

Journal of Medical Microbiology

Volumn 61, Issue PART12, 2012, Pages 1662-1668

  Litt, David J ^a   Jauneikaite, Elita ^a   Tchipeva, Draga ^a,b   Harrison, Timothy G ^a   Fry, Norman K ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; DNA SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT;

BORDETELLA INFECTIONS; BORDETELLA PERTUSSIS; DNA FINGERPRINTING; DNA, BACTERIAL; HUMANS; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84869413439     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.049585-0     Document Type: Article

References (36)

1. Bottero, D., Gaillard, M. E., Fingermann, M., Weltman, G., Fernández, J., Sisti, F., Graieb, A., Roberts, R., Rico, O. & other authors (2007). Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol 14, 1490-1498.
2. Bouchez, V., Brun, D., Cantinelli, T., Dore, G., Njamkepo, E. & Guiso, N. (2009). First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 27, 6034-6041.
3. Boursaux-Eude, C., Thiberge, S., Carletti, G. & Guiso, N. (1999). Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine. Vaccine 17, 2651-2660.
4. Campbell, H., Amirthalingam, G., Andrews, N., Fry, N. K., George, R. C., Harrison, T. G. & Miller, E. (2012). Accelerating control of pertussis in England and Wales. Emerg Infect Dis 18, 38-47.
5. Celentano, L. P., Massari, M., Paramatti, D., Salmaso, S., Tozzi, A. E. & the EUVAC-NET Group (2005). Resurgence of pertussis in Europe. Pediatr Infect Dis J 24, 761-765.
6. Chan, W.-F., Maharjan, R. P., Reeves, P. R., Sintchenko, V., Gilbert, G. L. & Lan, R. (2009). Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis. J Microbiol Methods 77, 326-329.
7. Denoël, P., Godfroid, F., Guiso, N., Hallander, H. & Poolman, J. (2005). Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model. Vaccine 23, 5333-5341.
8. Fry, N. K., Duncan, J., Wagner, K., Tzivra, O., Doshi, N., Litt, D. J., Crowcroft, N., Miller, E., George, R. C. & Harrison, T. G. (2009). Role of PCR in the diagnosis of pertussis infection in infants: 5 years' experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J Med Microbiol 58, 1023-1029.
9. Gzyl, A., Augustynowicz, E., Gniadek, G., Rabczenko, D., Dulny, G. & Ślusarczyk, J. (2004). Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates. Vaccine 22, 2122-2128.
10. Hegerle, N., Paris, A.-S., Brun, D., Dore, G., Njamkepo, E., Guillot, S. & Guiso, N. (2012). Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect 18, E340-E346.
11. King, A. J., Berbers, G., van Oirschot, H. F. L. M., Hoogerhout, P., Knipping, K. & Mooi, F. R. (2001). Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology 147, 2285-2289.
12. Komatsu, E., Yamaguchi, F., Abe, A., Weiss, A. A. & Watanabe, M. (2010). Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model. Clin Vaccine Immunol 17, 807-812.
13. Litt, D. J., Neal, S. E. & Fry, N. K. (2009). Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol 47, 680-688.
14. Mä kinen, J., Mertsola, J., Viljanen, M. K., Arvilommi, H. & He, Q. (2002). Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis. J Clin Microbiol 40, 2213-2216.
15. Mattoo, S. & Cherry, J. D. (2005). Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18, 326-382.
16. Mooi, F. R. (2010). Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol 10, 36-49.
17. Mooi, F. R., He, Q., van Oirschot, H. & Mertsola, J. (1999). Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun 67, 3133-3134.
18. Mooi, F. R., Hallander, H., Wirsing von Kö nig, C. H., Hoet, B. & Guiso, N. (2000). Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 19, 174-181.
19. Mooi, F. R., He, Q. & Guiso, N. (2007). Phylogeny, evolution, and epidemiology of Bordetellae. In Bordetella Molecular Microbiology, pp. 17-45. Edited by C. Locht. Norfolk, UK: Horizon Bioscience.
20. Mooi, F. R., van Loo, I. H. M., van Gent, M., He, Q., Bart, M. J., Heuvelman, K. J., de Greeff, S. C., Diavatopoulos, D., Teunis, P. & other authors (2009). Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15, 1206-1213.
21. Muyldermans, G., Soetens, O., Antoine, M., Bruisten, S., Vincart, B., Doucet-Populaire, F., Fry, N. K., Olcé n, P., Scheftel, J. M. & other authors (2005). External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J Clin Microbiol 43, 30-35.
22. Nakamura, Y., Kamachi, K., Toyoizumi-Ajisaka, H., Otsuka, N., Saito, R., Tsuruoka, J., Katsuta, T., Nakajima, N., Okada, K. & other authors (2011). Marked difference between adults and children in Bordetella pertussis DNA load in nasopharyngeal swabs. Clin Microbiol Infect 17, 365-370.
23. Ntezayabo, B., De Serres, G. & Duval, B. (2003). Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J 22, 22-27.
24. Octavia, S., Maharjan, R. P., Sintchenko, V., Stevenson, G., Reeves, P. R., Gilbert, G. L. & Lan, R. (2011). Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection. Mol Biol Evol 28, 707-715.
25. Packard, E. R., Parton, R., Coote, J. G. & Fry, N. K. (2004). Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol 53, 355-365.
26. Parkhill, J., Sebaihia, M., Preston, A., Murphy, L. D., Thomson, N., Harris, D. E., Holden, M. T. G., Churcher, C. M., Bentley, S. D. & other authors (2003). Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35, 32-40.
27. Poynten, M., McIntyre, P. B., Mooi, F. R., Heuvelman, K. J. & Gilbert, G. L. (2004). Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol Infect 132, 185-193.
28. Register, K. B. & Sanden, G. N. (2006). Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis. J Clin Microbiol 44, 4577-4583.
29. Reischl, U., Lehn, N., Sanden, G. N. & Loeffelholz, M. J. (2001). Realtime PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J Clin Microbiol 39, 1963-1966.
30. Riffelmann, M., Wirsing von Kö nig, C. H., Caro, V., Guiso, N. & the Pertussis PCR Consensus Group (2005). Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 43, 4925-4929.
31. Robinson, A., Gorringe, A. R., Funnell, S. G. & Fernandez, M. (1989). Serospecific protection of mice against intranasal infection with Bordetella pertussis. Vaccine 7, 321-324.
32. Schouls, L. M., van der Heide, H. G. J., Vauterin, L., Vauterin, P. & Mooi, F. R. (2004). Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol 186, 5496-5505.
33. Tanaka, M., Vitek, C. R., Pascual, F. B., Bisgard, K. M., Tate, J. E. & Murphy, T. V. (2003). Trends in pertussis among infants in the United States, 1980-1999. JAMA 290, 2968-2975.
34. Tsang, R. S.W., Lau, A. K. H., Sill, M. L., Halperin, S. A., Van Caeseele, P., Jamieson, F. & Martin, I. E. (2004). Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J ClinMicrobiol 42, 5364-5367.
35. van Gent, M., Bart, M. J., van der Heide, H. G. J., Heuvelman, K. J., Kallonen, T., He, Q., Mertsola, J., Advani, A., Hallander, H. O. & other authors (2011). SNP-based typing: a useful tool to study Bordetella pertussis populations. PLoS ONE 6, e20340.
36. van Loo, I. H. M., Heuvelman, K. J., King, A. J. & Mooi, F. R. (2002). Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol 40, 1994-2001.